Diagnostic products and services in the US had been witnessing a strong demand over the past few years, backed by favorable reimbursement policies for clinical lab testing, increasing awareness about early disease detection, and ever increasing aging population.
The US diagnostic market accounts majorly in the total healthcare market. The market is anticipated to sustain its growth pace in the coming years also, which will attract investors across the world.
According to our research report, “US Diagnostic Market Outlook 2014”, the US represents world’s largest and one of the most developed diagnostic markets. Huge investment in research and developments and commercially successful technological innovations in diagnostic industry is facilitating the US to outperform other prominent diagnostic markets including EU, Japan, and many other countries, etc. Looking ahead, the US is expected to maintain its lead position as the world's highest IVD products demand, growing at a moderate CAGR of around 9% during 2010-2014.
Our segment-level analysis showed that clinical chemistry is grabbing the biggest market share of the total IVD products demand. Although the segment’s future growth is expected to witness a slow growth, yet it is likely to sustain its topmost position in the market by 2014. Considering the growth rates, the demand for molecular diagnostic IVD products is anticipated to outpace all the other segments, owing to selectivity, sensitivity, speed, accuracy, and breadth of application advantages over alternative IVDs.
Our report, “US Diagnostic Market Outlook 2014” has been authored to evaluate the US diagnostic market potentials and identify future growth opportunities. It provides extensive research and analysis on current market trends and future forecasts on all prominent diagnostic techniques including clinical chemistry, immunoassays, blood testing, and molecular diagnostic.
The report also provides an insight into the competitive landscape of both diagnostics and lab services market. The future analysis of the market scenario is likely to assist the intending clients to take informed and proactive business decisions in the fast growing US diagnostic market.
